Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 51
Filtrar
1.
Sci Rep ; 13(1): 4006, 2023 03 10.
Artículo en Inglés | MEDLINE | ID: mdl-36899010

RESUMEN

Myocardial inflammation following myocardial infarction (MI) is crucial for proper myocardial healing, yet, dysregulated inflammation may promote adverse ventricular remodeling and heart failure. IL-1 signaling contributes to these processes, as shown by dampened inflammation by inhibition of IL-1ß or the IL-1 receptor. In contrast, the potential role of IL-1α in these mechanisms has received much less attention. Previously described as a myocardial-derived alarmin, IL-1α may also act as a systemically released inflammatory cytokine. We therefore investigated the effect of IL-1α deficiency on post-MI inflammation and ventricular remodeling in a murine model of permanent coronary occlusion. In the first week post-MI, global IL-1α deficiency (IL-1α KO mice) led to decreased myocardial expression of IL-6, MCP-1, VCAM-1, hypertrophic and pro-fibrotic genes, and reduced infiltration with inflammatory monocytes. These early changes were associated with an attenuation of delayed left ventricle (LV) remodeling and systolic dysfunction after extensive MI. In contrast to systemic Il1a-KO, conditional cardiomyocyte deletion of Il1a (CmIl1a-KO) did not reduce delayed LV remodeling and systolic dysfunction. In conclusion, systemic Il1a-KO, but not Cml1a-KO, protects against adverse cardiac remodeling after MI due to permanent coronary occlusion. Hence, anti-IL-1α therapies could be useful to attenuate the detrimental consequences of post-MI myocardial inflammation.


Asunto(s)
Interleucina-1alfa , Infarto del Miocardio , Remodelación Ventricular , Animales , Ratones , Oclusión Coronaria/complicaciones , Modelos Animales de Enfermedad , Inflamación/complicaciones , Interleucina-1alfa/metabolismo , Infarto del Miocardio/metabolismo , Miocarditis/complicaciones , Remodelación Ventricular/fisiología
2.
Eur Rev Med Pharmacol Sci ; 25(20): 6295-6299, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34730209

RESUMEN

Ethylene glycol is a toxic alcohol which may induce significant toxicity when ingested accidentally or intentionally. The main clinical complications of EG poisoning include central nervous system depression, cardiorespiratory instability and renal failure, which may be lethal if improperly treated. Although the demonstration of high plasma levels of ethylene glycol confirms the intoxication, such measurements are generally not obtained in the acute setting and can be misleading due to the rapid metabolism of EG. This implies the need for alternative, indirect, diagnostic methods, which reflect the metabolic fate of EG. These include an early and transient osmolar gap, followed by an anion gap metabolic acidosis and hyperoxaluria. Another frequent finding is a lactate gap between various methods of lactate measurements. An appropriate knowledge of these laboratory findings is essential for the diagnosis of EG poisoning, and for the initiation of antidote therapy (fomepizole) and hemodialysis in selected cases. These features are illustrated by the presentation of a prototypical case of EG poisoning, in which an incomplete diagnostic workup on hospital admission resulted in an unnecessary laparotomy and a significant delay in the management of the intoxication.


Asunto(s)
Antídotos/administración & dosificación , Glicol de Etileno/envenenamiento , Hiperoxaluria/etiología , Acidosis/etiología , Diagnóstico Tardío , Femenino , Fomepizol/administración & dosificación , Humanos , Persona de Mediana Edad , Intoxicación/diagnóstico , Intoxicación/terapia , Diálisis Renal/métodos
3.
Placenta ; 35(9): 784-6, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25043672

RESUMEN

We evaluated whether preeclampsia is associated with elevated circulating levels of High mobility group box 1 protein (HMGB-1), a nuclear protein with proinflammatory effects when released extracellularly. We enrolled 48 women, 32 in third trimester pregnancy (16 with, 16 without preeclampsia), and 16 healthy non pregnant. In the peripheral blood of pregnant women, HMGB-1 concentration was assessed serially, before and after delivery. With or without preeclampsia, third trimester pregnancy was associated with elevated levels of HMGB-1. This elevation is exaggerated in preeclampsia. The source of HMGB-1 observed in these conditions is likely to involve tissues other than the placenta itself.


Asunto(s)
Proteína HMGB1/sangre , Preeclampsia/sangre , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Embarazo
4.
Rev Med Suisse ; 10(454): 2362-7, 2014 Dec 10.
Artículo en Francés | MEDLINE | ID: mdl-25632631

RESUMEN

Mortality of the acute respiratory distress syndrome (ARDS) remains extremely high and only few evidence-based specific treatments are currently available. Protective mechanical ventilation has emerged as the comer stone of the management of ARDS to avoid the occurrence of ventilation-induced lung injuries (VILI). Mechanical ventilation in the prone position has often been considered as a rescue therapy reserved to refractory hypoxemia. Since the publication of the PROSEVA study in 2013, early prone positioning for mechanical ventilation should be recommended to improve survival of patients with severe ARDS. In this article, both the theoretical and practical aspects of mechanical ventilation in prone position are reviewed.


Asunto(s)
Posición Prona , Respiración Artificial/métodos , Síndrome de Dificultad Respiratoria/terapia , Hemodinámica , Humanos , Práctica Profesional , Síndrome de Dificultad Respiratoria/fisiopatología
5.
Pregnancy Hypertens ; 2(3): 306-7, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-26105447

RESUMEN

INTRODUCTION: A central pathogenic mechanism of preeclampsia is believed to be the production by the hypoxic placenta of various mediators which promote inflammation and oxidative stress when released into the maternal circulation. The high mobility group box 1 protein (HMGB1) is a ubiquitous nuclear protein. In conditions of hypoxic cellular stress or necrosis, HMGB1 is released into the extracellular milieu. Extracellular HMGB1 has proinflammatory effects, due to the engagement of various cell membrane receptors, notably the receptor for advanced glycation products (RAGE). OBJECTIVES: In preeclampsia, there is evidence for activation of RAGE, and enhanced amounts of HMGB1 have also been demonstrated in the placenta and amniotic fluid, but not, so far, in maternal blood. We hypothesize therefore that, in preeclampsia, the concentration of HMGB1 is abnormally high in maternal blood. METHODS: We enrolled 16 women in third trimester pregnancy and suffering from preeclampsia (blood pressure > 140/90mmHg with significant proteinuria), 16 women with normal pregnancies who were matched pairwise with the former for BMI and gestation week, and 16 non pregnant healthy women, matched for age with the other two groups. HMGB1 was assessed in peripheral blood with a commercial ELISA kit. The variance between the three groups was appreciated using an ANOVA analysis. Significance was considered for a probability value of < 0.5. RESULTS: The median [interquartile range] HMGB1 concentrations (in ng/mL) were 2.1 [1.1-3.2] in preeclamptic pregnancies, 1.1 [1.0-1.2] in normal pregnancies (p<0.05 vs preeclamptic group), and 0.6 [0.5-0.8] in non pregnant women (p<0.01 vs both other groups). CONCLUSION: In third trimester pregnancy, the presence of preeclampsia is associated with an approximately two-fold increase of HMGB1 concentration in maternal peripheral blood. Considering its known proinflammatory effects, HMGB1 could be one mediator responsible for the maternal manifestations of preeclampsia.

6.
Scand J Med Sci Sports ; 21(6): e325-33, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21435019

RESUMEN

During recovery from a maximal or submaximal aerobic exercise, augmentation of central (aortic) systolic pressure by reflected pressure waves is blunted in healthy humans. However, the extent to which reflected pressure waves modify the central pulse in diastole in these conditions remains unknown. We evaluated systolic and diastolic central reflected waves in 11 endurance-trained athletes on recovery from a maximal running test on a treadmill (treadmill-max) and a 4000 m run in field conditions. On both occasions in each subject, the radial pulse was recorded with applanation tonometry in the resting preexercise state and then 5, 15, 25, 35, and 45 min after exercise termination. From the central waveform, as reconstructed by application of a generalized transfer function, we computed a systolic (AIx) and a diastolic index (AId) of pressure augmentation by reflections. At 5 min, both indices were below preexercise. At further time-points, AIx remained low, while AId progressively increased, to overshoot above preexercise at 45 min. The same behavior was observed with both exercise types. Beyond the first few minutes of recovery following either maximal or submaximal aerobic exercise, reflected waves selectively augment the central pressure pulse in diastole, at least in endurance-trained athletes.


Asunto(s)
Presión Sanguínea/fisiología , Arteria Braquial , Ejercicio Físico/fisiología , Adulto , Determinación de la Presión Sanguínea/métodos , Prueba de Esfuerzo/métodos , Hemodinámica/fisiología , Humanos , Masculino , Suiza , Adulto Joven
7.
Rev Med Suisse ; 7(321): 2435-8, 2011 Dec 14.
Artículo en Francés | MEDLINE | ID: mdl-22279861

RESUMEN

The hemodynamics of septic shock is characterized by a primary reduction of vascular tone, which defines vasoplegia. Septic vasoplegia is due to reduced endogenous production of vasopressin, as well as to the overproduction of vasodilating molecules (nitric oxide, prostacyclin, peroxynitrite and kynurenine) and the opening of ATP-sensitive potassium channels. Treatment is supportive and includes primarily alpha-adrenergic catecholamines. Vasopressin may also be useful, although its place is still controversial. Further agents can improve the vascular responsiveness to catecholamines, most notably low doses hydrocortisone, and, to a lesser extent, activated protein C. Further, innovative therapies, based on recent understanding of pathophysiological mechanisms, might become useful agents to treat septic vasoplegia in the future.


Asunto(s)
Choque Séptico/complicaciones , Choque Séptico/terapia , Vasoplejía/etiología , Vasoplejía/terapia , Catecolaminas/uso terapéutico , Humanos , Hidrocortisona/uso terapéutico , Canales KATP/metabolismo , Canales KATP/fisiología , Modelos Biológicos , Óxido Nítrico/efectos adversos , Óxido Nítrico/metabolismo , Óxido Nítrico/fisiología , Ácido Peroxinitroso/efectos adversos , Ácido Peroxinitroso/metabolismo , Ácido Peroxinitroso/fisiología , Prostaglandinas I/efectos adversos , Prostaglandinas I/metabolismo , Prostaglandinas I/fisiología , Proteína C/uso terapéutico , Choque Séptico/metabolismo , Transducción de Señal/fisiología , Vasoplejía/metabolismo , Vasopresinas/uso terapéutico
8.
Physiol Res ; 57(5): 685-692, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-17949255

RESUMEN

Reactive hyperemia (RH) in forearm muscle or skin microcirculation has been considered as a surrogate endpoint in clinical studies of cardiovascular disease. We evaluated two potential confounders that might limit such use of RH, namely laterality of measurement and intake of non-steroidal anti-inflammatory drugs (NSAIDS). Twenty-three young non-smoking healthy adults were enrolled. In Experiment 1 (n=16), the RH elicited by 3 min of ischemia was recorded in the muscle (strain gauge plethysmography, hand excluded) and skin (laser Doppler imaging) of both forearms. In Experiment 2 (n=7), RH was determined in the dominant forearm only, one hour following oral acetylsalicylic acid (1 g) or placebo. In Experiment 1, peak RH was identical in both forearms, and so were the corresponding durations of responses. RH lasted significantly less in muscle than in skin (p=0.003), a hitherto unrecognized fact. In the skin, acetylsalicylate reduced duration (43 vs. 57.4 s for placebo, p=0.03), without affecting the peak response. In muscle, duration tended to decrease with acetylsalicylate (21.4 vs. 26.0 s with placebo, p=0.06) and the peak increase in blood flow was blunted (27.2 vs. 32.4 ml/min/100 ml tissue with placebo, p=0.003). We conclude that, when using RH as a surrogate endpoint in studies of cardiovascular disease, a confounding by laterality of measurement need not be feared, but NSAIDS may have an influence, although perhaps not on the peak response in the skin.


Asunto(s)
Hiperemia/fisiopatología , Microcirculación/efectos de los fármacos , Músculo Esquelético/irrigación sanguínea , Piel/irrigación sanguínea , Administración Oral , Adolescente , Adulto , Aspirina/administración & dosificación , Velocidad del Flujo Sanguíneo , Inhibidores de la Ciclooxigenasa/administración & dosificación , Antebrazo , Humanos , Hiperemia/prevención & control , Flujometría por Láser-Doppler , Masculino , Pletismografía , Flujo Sanguíneo Regional , Reproducibilidad de los Resultados , Factores de Tiempo , Adulto Joven
9.
Rev Med Suisse ; 4(183): 2686-8, 2690, 2008 Dec 10.
Artículo en Francés | MEDLINE | ID: mdl-19157282

RESUMEN

Despite recent medical progresses in patient support, the mortality of sepsis remains high. Recently, new supporting strategies were proposed to improve outcome. Whereas such strategies are currently considered as standard of care, their real impact on mortality, morbidity, length of stay, and hence, health care resources utilization has been only weakly evaluated so far. Obviously, there is a critical need for epidemiologic surveys of sepsis to better address these major issues. The Lausanne Cohort of septic patients aims at building a large clinical, biological and microbiological database that will be used as a multidisciplinary research platform to study the various pathogenic mechanisms of sepsis in collaboration with the various specialists. This could be an opportunity to strengthen the collaboration within the Swiss Latin network of Intensive Care Medicine.


Asunto(s)
Investigación Biomédica , Cuidados Críticos , Sepsis/terapia , Estudios de Cohortes , Conducta Cooperativa , Cuidados Críticos/tendencias , Bases de Datos como Asunto , Diagnóstico Diferencial , Humanos , Proyectos Piloto , Sepsis/diagnóstico , Sepsis/fisiopatología , Choque Séptico/diagnóstico , Choque Séptico/fisiopatología , Choque Séptico/terapia , Suiza , Síndrome de Respuesta Inflamatoria Sistémica/diagnóstico , Síndrome de Respuesta Inflamatoria Sistémica/fisiopatología , Síndrome de Respuesta Inflamatoria Sistémica/terapia
10.
Praxis (Bern 1994) ; 96(29-30): 1137-40, 2007 Jul 18.
Artículo en Francés | MEDLINE | ID: mdl-17691449

RESUMEN

Until today, the usual way to measure arterial blood pressure has been cuff sphygmomanometry, at the level of the brachial artery. Yet, for some years, a non invasive tool has been available, that enables an estimation of the aortic pressure. This is done by using an aplanation tonometry technique to record the pulse wave within the radial artery, with subsequent convertion to a central pressure wave by means of a mathematical method (transfer function). This measurement informs us about the pressure near the target organs: this pressure is influenced by the reflected waves, which are responsible for an augmentation of systolic blood pressures when arterial compliance is abnormally low. Recent clinical trials have shown that for the same value of peripheral blood pressure, different antihypertensive treatments may not impact identically on central blood pressure.


Asunto(s)
Aorta , Determinación de la Presión Sanguínea/métodos , Manometría/métodos , Adulto , Antihipertensivos/uso terapéutico , Arteria Braquial , Humanos , Hipertensión/diagnóstico , Hipertensión/tratamiento farmacológico , Persona de Mediana Edad , Sensibilidad y Especificidad , Esfigmomanometros
11.
Neurology ; 69(3): 255-60, 2007 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-17636063

RESUMEN

BACKGROUND: Prognosis of status epilepticus (SE) depends on its cause, but there is uncertainty as to whether SE represents an independent outcome predictor for a given etiology. Cerebral anoxia is a relatively homogenous severe encephalopathy. Postanoxic SE is associated to a nearly 100% mortality in this setting; however, it is still unclear whether this is a severity marker of the underlying encephalopathy, or an independent factor influencing outcome. The goal of this study was to assess if postanoxic SE is independently associated with mortality after cerebral anoxia. METHODS: This was a retrospective observation of consecutive comatose survivors of cardiac arrest, including subjects treated with hypothermia. On the subgroup with EEG recordings in the first hospitalization days, univariate and multivariate analyses were applied to potential determinants of in-hospital mortality, and included the following variables: age, gender, type and length of cardiac arrest, occurrence of circulatory shock, presence of therapeutic hypothermia, and electrographic SE. RESULTS: Out of 166 postanoxic patients, 107 (64%) had an EEG (median latency from admission, 2 days); in this group, therapeutic hypothermia was administered in 59%. Death occurred in 71 (67%) patients. Postanoxic SE was associated with mortality regardless of type of acute cardiac rhythm and administration of hypothermic treatment. CONCLUSION: In this hospital-based cohort, postanoxic status epilepticus (SE) seems to be independently related to death in cardiac arrest survivors, suggesting that SE might determine a bad prognosis for a given etiology. Confirmation of these results in a prospective assessment is needed.


Asunto(s)
Hipoxia Encefálica/epidemiología , Estado Epiléptico/epidemiología , Adulto , Anciano , Estudios de Cohortes , Femenino , Paro Cardíaco/complicaciones , Paro Cardíaco/epidemiología , Paro Cardíaco/fisiopatología , Humanos , Hipoxia Encefálica/etiología , Hipoxia Encefálica/fisiopatología , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Factores de Riesgo , Estado Epiléptico/etiología , Estado Epiléptico/fisiopatología , Resultado del Tratamiento
12.
Eur J Vasc Endovasc Surg ; 31(4): 401-6, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16359880

RESUMEN

INTRODUCTION: The aim of this study was to assess the blood flow in the feet before and after lower limb revascularization using laser Doppler imaging (LDI). METHODS: Ten patients with critical lower limb ischemia were prospectively enrolled from June to October 2004. All patients underwent successful unilateral surgical interventions including above-knee bypass, distal bypass and endarterectomy. Skin blood flow (SBF) over the plantar surface of both forefeet and heels was measured by LDI 24h before and 10 days after revascularization, expressed in perfusion units (PU), and reported as mean+/-SD. RESULTS: Measurements in the forefoot and heel were similar. Before revascularization mean SBF was significantly lower in the ischemic foot (130+/-71 PU) compared to the contralateral foot (212+/-68 PU), p<0.05. After revascularization a significant increase of the SBF in the forefoot (from 135+/-67 to 202+/-86 PU, p=0.001) and hindfoot (from 148+/-58 to 203+/-83, p=0.001) was observed on the treatment side. However, a large decrease of the SBF was seen in forefoot and hindfoot on the untreated side (from 250+/-123 PU to 176+/-83 and from 208+/-116 to 133+/-40, p=0.001, respectively). CONCLUSION: This study confirms the benefits of revascularization in patients with nonhealing foot lesions due to critical limb ischemia. A significant increase of the SBF was observed on the treatment side. However, an unexpected decrease was observed on the untreated side.


Asunto(s)
Pie/irrigación sanguínea , Isquemia/cirugía , Flujometría por Láser-Doppler , Pierna/irrigación sanguínea , Anciano , Anciano de 80 o más Años , Presión Sanguínea , Determinación de la Presión Sanguínea , Endarterectomía , Femenino , Arteria Femoral/cirugía , Humanos , Masculino , Persona de Mediana Edad , Pletismografía , Arteria Poplítea/cirugía , Estudios Prospectivos
13.
Rev Med Suisse ; 2(91): 2871-4, 2006 Dec 13.
Artículo en Francés | MEDLINE | ID: mdl-17236328

RESUMEN

The merging of two intensive care units is a time of profound change, and constitutes a risk of mishaps. We report some aspects of such a project in our institution. The evaluation of various indicators reflecting the activity, patient's hospital pathways, mortality, as well as the use of specific techniques, has shown that no particular problem was observed during the first 9 months. Improvements in performance or productivity have not been demonstrated so far. The follow-up will permit to demonstrate long-term benefits. We believe that these observations may be of interest for other departmental or hospital reorganisations.


Asunto(s)
Instituciones Asociadas de Salud/organización & administración , Unidades de Cuidados Intensivos/organización & administración , Humanos , Suiza
14.
J Mol Cell Cardiol ; 38(5): 765-75, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15850570

RESUMEN

Peroxynitrite is a potent oxidant and nitrating species proposed as a direct effector of myocardial damage in a wide range of cardiac diseases. Whether peroxynitrite also acts indirectly, by modulating cell signal transduction pathways in the myocardium, has not been investigated. Here, we examined the ability of peroxynitrite to activate extracellular signal-related kinase (ERK), a MAP kinase which has been linked with hypertrophic and anti-apoptotic responses in the heart, in cultured H9C2 cardiomyocytes. Peroxynitrite elicited a concentration- and time-dependent activation of ERK, secondary to the upstream activation of MEK 1 (ERK kinase). Activation of MEK-ERK by peroxynitrite was related to the upstream activation of Raf-1 kinase, as ERK and MEK phosphorylation were prevented by the Raf-1 inhibitor BAY43-9006. These effects of peroxynitrite were not associated with the activation of p21(Ras), known as a common signaling target of cellular oxidative stress. In contrast to ERK activation mediated by the epidermal growth factor (EGF), ERK activation by peroxynitrite was not prevented by AG1478 (EGF receptor inhibitor). Peroxynitrite acted through oxidative, but not nitrative chemistry, as ERK remained activated while nitration was prevented by the flavanol epicatechin. In addition to ERK, peroxynitrite also potently activated two additional members of the MAP kinase family of signaling proteins, JNK and p38. Thus, peroxynitrite activates ERK in cardiomyocytes through an unusual signaling cascade involving Raf-1 and MEK 1, independently from EGFR and P21(Ras), and also acts as a potent activator of JNK and p38. These results provide the novel concept that peroxynitrite may represent a previously unrecognized signaling molecule in various cardiac pathologies.


Asunto(s)
Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Quinasas de Proteína Quinasa Activadas por Mitógenos/metabolismo , Miocitos Cardíacos/efectos de los fármacos , Miocitos Cardíacos/metabolismo , Ácido Peroxinitroso/toxicidad , Proteínas Proto-Oncogénicas c-raf/metabolismo , Animales , Línea Celular , Activación Enzimática/efectos de los fármacos , Receptores ErbB/metabolismo , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Oxidantes/toxicidad , Proteínas Proto-Oncogénicas p21(ras)/metabolismo , Ratas , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
15.
Rev Med Suisse ; 1(6): 448-51, 2005 Feb 09.
Artículo en Francés | MEDLINE | ID: mdl-15786650

RESUMEN

So far, cardiac arrest is still associated with high mortality or severe neurological disability in survivors. At the tissue level, cardiac arrest results into an acute condition of generalized hypoxia. A better understanding of the pathophysiology of ischemia-reperfusion and of the inflammatory response that develops after cardiac arrest could help to design novel therapeutic strategies in the future. It seems unlikely that a single drug, acting as a <>, might be able to improve survival or neurological prognosis. Lessons learned from pathophysiological mechanisms rather indicate that combined therapies, involving thrombolysis, neuroprotective agents, antioxidants and anti-inflammatory molecules, together with temperature cooling, might represent helpful strategies to improve patient's outcome after cardiac arrest.


Asunto(s)
Paro Cardíaco/prevención & control , Antiinflamatorios/uso terapéutico , Antioxidantes/uso terapéutico , Fibrinolíticos/uso terapéutico , Humanos , Fármacos Neuroprotectores/uso terapéutico
16.
J Antimicrob Chemother ; 54(1): 269-70, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15175271

RESUMEN

OBJECTIVES: To determine whether voriconazole dosage adjustment is required during continuous veno-venous haemodiafiltration (CVVHDF). METHODS: Voriconazole pharmacokinetics were studied in a critically ill patient under CVVHDF. The analysis was carried out for 12 h following a 6 mg/kg dose. Voriconazole concentrations were measured by HPLC in blood inlet and outlet lines and in dialysate. RESULTS: The total body clearance of voriconazole was 20.3 L/h, with a terminal half-life of 13.7 h and a distribution volume of 399 L. The estimated sieving coefficient was 0.53 and the filtration-dialysis clearance 1.2 L/h. CONCLUSIONS: CVVHDF does not significantly affect voriconazole disposition and requires no dosage adjustment.


Asunto(s)
Antifúngicos/farmacocinética , Hemofiltración , Pirimidinas/farmacocinética , Triazoles/farmacocinética , Anciano , Antifúngicos/sangre , Antifúngicos/uso terapéutico , Área Bajo la Curva , Cromatografía Líquida de Alta Presión , Resultado Fatal , Femenino , Semivida , Humanos , Fallo Renal Crónico/metabolismo , Fallo Renal Crónico/terapia , Neumonía por Pneumocystis/complicaciones , Neumonía por Pneumocystis/tratamiento farmacológico , Pirimidinas/sangre , Pirimidinas/uso terapéutico , Síndrome de Dificultad Respiratoria/complicaciones , Síndrome de Dificultad Respiratoria/tratamiento farmacológico , Triazoles/sangre , Triazoles/uso terapéutico , Voriconazol
17.
Int J Impot Res ; 15(6): 461-4, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14671668

RESUMEN

The aim of the present study was to test the effects of a topical administration of a novel nitric oxide donor, linear polyethylenimine-nitric oxide/nucleophile adduct (DS1), on vaginal blood flow and hemodynamics in rats. Laser Doppler flowmetry was used to measure blood flow changes following topical application of DS1 (0.3 or 1.5 mg in 0.15 ml saline) into the vagina of anesthetized Wistar rats. In vivo hemodynamic parameters were measured with Millar-tip-catheter placed in the left ventricle. DS1 (1.5 mg) increased vaginal blood flow by 191+/-24, 226+/-22 and 166+/-23% of the baseline value (at 5, 15 and 30 min, respectively, after application) without affecting systemic blood pressure, heart rate and cardiac function. The increased vaginal blood flow following DS1 application returned to baseline between 45 and 60 min. Thus, topical application of nitric oxide donors such as DS1 may be useful for the treatment of female sexual dysfunction that develops due to an impairment of local blood flow supply to the vaginal tissue.


Asunto(s)
Donantes de Óxido Nítrico/farmacología , Compuestos Nitrosos/farmacología , Polietileneimina/farmacología , Flujo Sanguíneo Regional/efectos de los fármacos , Vagina/irrigación sanguínea , Administración Tópica , Anestesia , Animales , Femenino , Ratas , Ratas Wistar
18.
Am J Physiol Gastrointest Liver Physiol ; 284(1): G138-44, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12388199

RESUMEN

Inosine, a naturally occurring purine formed from the breakdown of adenosine, has recently been shown to exert powerful anti-inflammatory effects both in vivo and in vitro. This study evaluated inosine as a potential therapy for colitis. Colitis was induced in mice by the administration of dextran sulfate sodium (DSS). Oral treatment with inosine was begun either before the onset of colitis or as a posttreatment once colitis was established. Evaluation of colon damage and inflammation was determined grossly (body wt, rectal bleeding), histologically, and biochemically (colon levels of MPO, MDA, and cytokines). DSS-induced colitis significantly increased inflammatory cell infiltration into the colon. DSS-induced colitis also increased colon levels of lipid peroxidation, cytokines, and chemokines. Inosine protected the colon from DSS-induced inflammatory cell infiltration and lipid peroxidation. Inosine also partially reduced these parameters in an experimental model of established colitis. Thus inosine treatment may be a potential therapy in colitis.


Asunto(s)
Colitis/tratamiento farmacológico , Inosina/farmacología , Animales , Anticoagulantes , Colitis/inducido químicamente , Colitis/mortalidad , Colon/metabolismo , Citocinas/metabolismo , Sulfato de Dextran , Modelos Animales de Enfermedad , Masculino , Ratones , Ratones Endogámicos BALB C , Tasa de Supervivencia
20.
J Endocrinol ; 173(3): 457-64, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12065235

RESUMEN

Insulin-dependent diabetes mellitus (IDDM) is a disease characterized by the autoimmune destruction of the pancreatic beta-cells, which requires the expression of a number of immune-related genes including major histocompatibility complex proteins, cytokines, chemokines, and cytotoxic enzymes, many of which are regulated by the transcription factor, NFkappaB. Inhibition of the entire NFkappaB family of transcription factors may be harmful, as these factors are involved in many normal physiological processes. However, identifying and targeting specific NFkappaB subunits critical for the pathogenesis of disease may prove to be valuable in designing new therapeutic strategies. To assess the potential role of the NFkappaB subunit, p50, in the development of IDDM, mice with gene disruption for NFkappaB (p50) were investigated for susceptibility to IDDM. We found that p50-deficient mice were fully resistant against multiple low-dose streptozotocin-induced diabetes, a model of diabetes with a strong autoimmune component. The site of involvement of NFkappaB (p50) lies at an early, critical juncture of immune activation and proinflammatory mediator production, because: (1) isolated islets of Langerhans from NFkappaB (p50)-deficient mice were not protected from the islet dysfunction induced by in vitro application of proinflammatory cytokines; (2) p50-deficient mice were not resistant to diabetes induced by a single high dose of streptozotocin, a model with a large oxidant component and no autoimmune involvement; and (3) diabetes induced up-regulation of nitric oxide and interleukin-12 was blocked in the p50-deficient mice. Our data suggest that NFkappaB (p50) has an essential role in the development of autoimmune diabetes. Selective therapeutic blockade of this subunit may be beneficial in preventing IDDM.


Asunto(s)
Diabetes Mellitus Experimental/metabolismo , FN-kappa B/metabolismo , Animales , Citocinas/farmacología , Modelos Animales de Enfermedad , Susceptibilidad a Enfermedades , Esquema de Medicación , Glucosa/farmacología , Insulina/metabolismo , Secreción de Insulina , Islotes Pancreáticos/efectos de los fármacos , Islotes Pancreáticos/metabolismo , Ratones , Ratones Noqueados , FN-kappa B/genética , Subunidades de Proteína
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...